NAD+ vs. NMN vs. NR
Injectable NAD+ or oral NMN and NR supplements? The honest difference is oversight and quality control, not a winner.
Quick answer
NAD+, NMN, and NR are related but not interchangeable. NAD+ (nicotinamide adenine dinucleotide) is the coenzyme your cells actually use; NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors, molecules the body converts along the pathway toward NAD+. NMN and NR are sold over the counter as supplements; physician-directed NAD+ at Kesbury Health is a compounded, prescribed medication given as an at-home subcutaneous injection. The honest difference is not that one is universally more effective, large head-to-head human trials have not established that. It is practical: an OTC precursor is self-directed with variable quality and no clinical oversight, while physician-directed NAD+ is prescribed, quality-controlled, individualized, and monitored. NAD+ may support general wellness and cellular-health goals rather than treat any condition, and individual results vary.
What are NAD+, NMN, and NR?
- NAD+ is the working coenzyme. It is the molecule your mitochondria, DNA-repair enzymes, and sirtuins actually spend (see the cornerstone explainer, what is NAD+, for the full mechanism).
- NMN is nicotinamide mononucleotide, a precursor one step away from NAD+ in the salvage pathway. Taken orally as a supplement, it is intended to feed NAD+ production.
- NR is nicotinamide riboside, another precursor, a step earlier than NMN, also sold orally as a supplement and intended to be converted toward NAD+.
The simplest mental model: NMN and NR are ingredients the body routes toward NAD+, while NAD+ is the finished coenzyme. That difference in where each sits on the pathway is the source of much of the online debate, but it does not, on its own, tell you which approach is right for a given person.
Is one of them "better" than the others?
This is the question most people arrive with, and the honest answer is uncomfortable for marketers: comparative effectiveness has not been established in large head-to-head human trials. Reviews of NAD-related molecules describe the therapeutic potential as still being worked out, with much of the strongest data preclinical or early-stage [3]. Anyone claiming a precursor supplement definitively out-performs physician-directed NAD+, or vice versa, is reaching past the evidence.
So the useful comparison is not "which molecule wins." It is the practical axes that actually differ between buying a supplement off a shelf and following a prescribed, monitored protocol: oversight (is a physician reviewing your history and following your plan over time?), quality control (do you know what is actually in the product, at the stated potency?), personalization (is the protocol titrated to you, or one-size-fits-all?), and continuity (is there a care team to adjust the plan and answer questions?).
NAD+ injections vs NMN vs NR: a side-by-side comparison
| Physician-directed NAD+ (injection) | NMN supplement | NR supplement | |
|---|---|---|---|
| What it is | The NAD+ coenzyme itself, as a compounded medication | An oral NAD+ precursor (nicotinamide mononucleotide) | An oral NAD+ precursor (nicotinamide riboside) |
| How it's taken | At-home subcutaneous (SubQ) injection, after physician instruction | Oral capsule/powder, self-administered | Oral capsule/powder, self-administered |
| Oversight | Physician-prescribed and monitored; eligibility screened | None, over the counter, self-directed | None, over the counter, self-directed |
| Quality control | Dispensed by a licensed pharmacy | Varies by brand; supplement-grade, not standardized | Varies by brand; supplement-grade, not standardized |
| Personalization | Protocol titrated to the individual | Generic label dose | Generic label dose |
| Cost ballpark | $299/month, physician-directed (Kesbury Health) | Roughly $30-90/month, brand-dependent | Roughly $40-100/month, brand-dependent |
| Best for | People who want a prescribed, monitored, individualized plan with continuity of care | People who want a low-cost, self-directed OTC option and accept no oversight | People who want a low-cost, self-directed OTC option and accept no oversight |
The columns differ most on oversight, quality control, personalization, and continuity, not on a claim that the injection produces a better biological result. That is the honest distinction, and the one that maps to how the two paths actually feel in real life.
A note on quality and the regulatory picture
Two things are worth stating plainly, without alarmism:
- Supplement quality varies. OTC precursors are sold as dietary supplements, which are not held to the same potency-verification standards as a compounded medication dispensed by a licensed pharmacy. The practical takeaway is that "what's on the label" and "what's in the bottle" do not always match, choose third-party-tested products if you go the OTC route.
- NMN's regulatory status has been the subject of debate. The classification of NMN as a dietary supplement has been contested in the United States, and the picture has shifted over time. This is a factual, evolving situation, not a reason for alarm, but it is one more reason a physician-directed path offers more certainty about what you are taking.
None of this makes precursor supplements "bad." Many people use them. It does mean the self-directed, unmonitored nature of the OTC route is the real trade-off against a prescribed, monitored one.
Why people choose physician-directed NAD+
The reasons are about process, not a promise of a better outcome: a physician screens whether NAD+ is appropriate before anything is prescribed, the medication is compounded and dispensed by a licensed pharmacy at a known potency, the protocol is individualized, and a care team provides continuity, including guidance on side effects and safety, NAD+ dosage, and at-home injection. If you are instead weighing the injectable route against in-clinic intravenous NAD+, a different comparison, see NAD+ injections vs intravenous NAD+. NAD+ is a compounded, physician-prescribed medication, and individual results vary.
Frequently asked questions
What is the difference between NAD+, NMN, and NR?
NAD+ is the coenzyme your cells actually use. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors, molecules the body converts along the pathway toward NAD+. NMN and NR are sold over the counter as supplements; the NAD+ used in physician-directed therapy is a compounded, prescribed medication.
Is NMN better than NAD+ injections?
Comparative effectiveness has not been established in large head-to-head human trials, so neither can honestly be called universally "better." The meaningful difference is practical: NMN is a self-directed OTC supplement with variable quality and no physician oversight, while physician-directed NAD+ is prescribed, quality-controlled, individualized, and monitored. Individual results vary.
Is NMN or NR an over-the-counter supplement?
Yes. Both NMN and NR are sold over the counter as dietary supplements, taken orally and self-directed. By contrast, the NAD+ used in physician-directed therapy at Kesbury Health is a compounded medication, dispensed by a licensed pharmacy only after a physician reviews your health history.
Why is there debate about NMN's regulatory status?
The classification of NMN as a dietary supplement has been contested in the United States, and the regulatory picture has shifted over time. It is an evolving, factual situation rather than a cause for alarm, and it is one reason some people prefer a physician-directed path, where the source and potency of what they are taking are known.
Are NMN and NR supplements safe?
Many people use them, but supplements are not standardized the way a compounded medication is, so product quality varies by brand. If you choose the OTC route, third-party-tested products are preferable. Anyone with health conditions or on medications should consult a physician first, and individual results vary.
How do I get physician-directed NAD+ instead of a supplement?
Complete Kesbury Health's short online assessment, have a licensed physician review your goals and health history, and if it is clinically appropriate, your personalized NAD+ protocol is prescribed and shipped to your home. Eligibility depends on the state where you live.
Want oversight instead of guesswork?
If the appeal of physician-directed NAD+ is knowing exactly what you are taking, why, and that someone is following your plan, that is the real difference between a supplement off a shelf and a prescribed, monitored protocol. Start the Kesbury Health evaluation; a licensed physician reviews your goals and health history, and if NAD+ is clinically appropriate, your personalized plan ships to your door.
Kesbury Health is a LegitScript-certified telehealth longevity practice. NAD+ is a compounded medication prescribed only after physician review. This page is educational and is not individualized medical advice. Individual results vary.
What the published evidence shows
NMN and NR are both oral NAD+ precursors with published human trials showing they raise measured NAD+ and are generally well tolerated. No trial has established that either one beats the other, or that either changes an aging outcome in people.
The dose-response is documented for nicotinamide riboside. In a 2019 randomized, double-blind, placebo-controlled trial, 100, 300 and 1,000 mg per day raised whole-blood NAD+ by 22%, 51% and 142% respectively within two weeks, and the increases held for the rest of the 8-week study. A 2019 crossover trial gave 12 aged men 1 g of nicotinamide riboside daily for 21 days and found it reached skeletal muscle and lowered circulating inflammatory cytokines, without changing mitochondrial bioenergetics.
NMN has its own human trials rather than a shared one. A 2021 randomized trial in Science reported improved muscle insulin sensitivity in prediabetic postmenopausal women, and a 2023 dose-ranging trial in healthy middle-aged adults reported efficacy and safety outcomes across doses. These are different populations and different endpoints, which is exactly why a head-to-head winner cannot be read out of them.
So the honest comparison is not NMN versus NR on potency. It is supplement versus prescription on oversight: what is in the bottle, who checked your history first, and who is monitoring you afterwards. Individual results vary.
References (primary sources)
Every reference below was resolved and checked against its PubMed record on 2026-09-02. Links open the abstract. One title below carries a bracketed elision: the published title names a commercial supplement brand, and reproducing a brand name in our own published copy is what rule N-001 exists to prevent, so the brand is removed and the generic compound name kept. The verbatim title is one click away at the PMID link. Note what these studies are and are not: the human trials listed here tested oral NAD+ precursors (nicotinamide riboside and nicotinamide mononucleotide), not injected NAD+. They are cited for what they establish about NAD+ biology and precursor safety, not as evidence about a subcutaneous protocol.
- Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metabolism. 2018;27(3):513-528. doi:10.1016/j.cmet.2017.11.002. PMID 29249689.
- Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism. 2018;27(3):529-547. doi:10.1016/j.cmet.2018.02.011. PMID 29514064.
- Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of [brand name elided] nicotinamide riboside chloride in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Scientific Reports. 2019;9(1):9772. doi:10.1038/s41598-019-46120-z. PMID 31278280.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7. PMID 29599478.
- Yi L, Maier AB, Tao R, et al. The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29-43. doi:10.1007/s11357-022-00705-1. PMID 36482258.
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. doi:10.1126/science.abe9985. PMID 33888596.
Keep reading